Effect of age on myocardial infarction and thrombolysis.
Thrombolytic therapy has emerged as the treatment of choice for patients presenting with an acute myocardial infarction. Myocardial infarction is a major cause of morbidity and mortality in the elderly. Advancing age has been considered a relative contraindication to thrombolytic therapy despite the potential for the elderly to derive the greatest benefit from this therapy. This trend not to treat the elderly has been based on a perceived increased risk of complications. Available data pooled from several studies clearly show that the elderly benefit from thrombolytic therapy.